Its role Owner
Almac Group is a global contract development and manufacturing organization (CDMO) serving pharmaceutical and biotechnology companies. Headquartered in Craigavon, Northern Ireland, it operates across Europe, North America, and Asia. The group’s business units include Almac Sciences (small‑molecule API development and manufacture, custom synthesis, and analytical services), Almac Clinical Services (clinical supply and logistics), Almac Pharma Services (drug product development and commercial manufacturing), and Almac Diagnostic Services. Arran Chemical Company, part of the group, supports advanced chemical development and production.
Core capabilities span route scouting, process optimization, GMP API manufacture from kilo to multi‑ton scale, solid‑state and analytical development, chiral chemistry and biocatalysis, hazardous and high‑energy chemistry, as well as formulation, packaging, and clinical trial supply. Almac supports programs from early development through commercial supply, with quality systems aligned to major regulatory markets.
chemXplore tracks 2 projects involving Almac Group.
The record holds 2 completed projects.
The 2 that are completed, on hold or cancelled are in the record. See all 2 in chemXplore →
The company expands its API services with continuous flow technology, enhancing product quality, process safety, and efficiency. A 4-year strategy focuses on advanced synthesis methods.
active all projects
